ETF DAILY NEWS

CorMedix’s (CRMD) “Buy” Rating Reiterated at D. Boral Capital

D. Boral Capital restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a report released on Wednesday morning,Benzinga reports. D. Boral Capital currently has a $15.00 target price on the stock. A number of other equities research analysts have also issued reports on CRMD. Royal Bank of Canada lifted their target […]

Mar 8, 2025 - 08:45
 0
CorMedix’s (CRMD) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a report released on Wednesday morning,Benzinga reports. D. Boral Capital currently has a $15.00 target price on the stock. A number of other equities research analysts have also issued reports on CRMD. Royal Bank of Canada lifted their target […]
Read More

Tags:

Previous Article

Jefferies Financial Group Cuts Campbell Soup (NASDAQ:CPB) Price Target to $40.00

Next Article

ChromaDex (NASDAQ:CDXC) Price Target Raised to $8.10

Related Posts

Merck KGaA (MKKGY) to Release Quarterly Earnings on Thursday

Merck KGaA (MKKGY) to Release Quarterly Earnings on Thu...

Mar 4, 2025  0

Jamf (JAMF) Expected to Announce Quarterly Earnings on Thursday

Jamf (JAMF) Expected to Announce Quarterly Earnings on ...

Feb 25, 2025  0

ENI (NYSE:E) Shares Gap Up – Should You Buy?

ENI (NYSE:E) Shares Gap Up – Should You Buy?

Mar 9, 2025  0